Nasopharyngeal Diseases  >>  pemetrexed  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pemetrexed / Generic mfg.
NCT00630149: Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy

Completed
2
35
RoW
Pemetrexed (Alimta), Alimta
Sun Yat-sen University, Eli Lilly and Company
Nasopharyngeal Neoplasms
11/11
01/12

Download Options